Literature DB >> 28501333

Comparative effectiveness of faecal microbiota transplant by route of administration.

N D Gundacker1, A Tamhane2, J B Walker3, C D Morrow4, J M Rodriguez2.   

Abstract

The optimal route of delivery for faecal microbiota transplant (FMT) is unknown. This observational single-centre study analysed the two-week cure rates for all patients who received FMT from 2013 to 2016 according to route of delivery. Overall, nasogastric delivery of FMT was less effective than lower endoscopic delivery. When patients were stratified by illness severity, nasogastric delivery achieved similar cure rates in healthier individuals, whereas lower endoscopic delivery was preferred for relatively ill individuals. Nasogastric delivery may be less effective than lower endoscopic delivery; however, when taking the cost, preparation and potential risk into account, this difference may not be clinically significant for patients with mild disease.
Copyright © 2017 The Healthcare Infection Society. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Clostridium difficile; Colonoscopy; Faecal microbiota transplant; Nasogastric

Mesh:

Year:  2017        PMID: 28501333     DOI: 10.1016/j.jhin.2017.05.004

Source DB:  PubMed          Journal:  J Hosp Infect        ISSN: 0195-6701            Impact factor:   3.926


  7 in total

1.  Microbiota replacement for Clostridium difficile by capsule is as effective as via colonoscopy.

Authors:  Srishti Saha; Sahil Khanna
Journal:  J Thorac Dis       Date:  2018-04       Impact factor: 2.895

Review 2.  Orchestrating the fecal microbiota transplantation: Current technological advancements and potential biomedical application.

Authors:  Manisha Nigam; Abhaya Shikhar Panwar; Rahul Kunwar Singh
Journal:  Front Med Technol       Date:  2022-09-22

Review 3.  Clinical Practice Guidelines for Fecal Microbiota Transplantation in Korea.

Authors:  Tae-Geun Gweon; Yoo Jin Lee; Kyeong Ok Kim; Sung Kyun Yim; Jae Seung Soh; Seung Young Kim; Jae Jun Park; Seung Yong Shin; Tae Hee Lee; Chang Hwan Choi; Young-Seok Cho; Dongeun Yong; Jin-Won Chung; Kwang Jae Lee; Oh Young Lee; Myung-Gyu Choi; Miyoung Choi
Journal:  J Neurogastroenterol Motil       Date:  2022-01-30       Impact factor: 4.924

4.  Fecal microbiota transplantation for refractory diarrhea in immunocompromised diseases: a pediatric case report.

Authors:  Shuwen Zhong; Jingqing Zeng; Zhaohui Deng; Lirong Jiang; Bin Zhang; Kaihua Yang; Wenyu Wang; Tianao Zhang
Journal:  Ital J Pediatr       Date:  2019-08-28       Impact factor: 2.638

Review 5.  Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics.

Authors:  John Chulhoon Park; Sin-Hyeog Im
Journal:  Exp Mol Med       Date:  2020-09-10       Impact factor: 8.718

6.  Case series of successful treatment with fecal microbiota transplant (FMT) oral capsules mixed from multiple donors even in patients previously treated with FMT enemas for recurrent Clostridium difficile infection.

Authors:  Mahtab Chehri; Alice Højer Christensen; Sofie Ingdam Halkjær; Stig Günther; Andreas Munk Petersen; Morten Helms
Journal:  Medicine (Baltimore)       Date:  2018-08       Impact factor: 1.817

7.  Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection.

Authors:  Minghuan Jiang; Nok-Hang Leung; Margaret Ip; Joyce H S You
Journal:  PLoS One       Date:  2018-07-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.